P

Inventor

HAN XIAOJUN

US23 patents
⚠️ This page may combine multiple inventors who share the name “HAN XIAOJUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

16 patents
US7834007B2Nov 16, 2010

CGRP antagonists

BRISTOL MYERS SQUIBB CO9 citations84
US7842808B2Nov 30, 2010

Anti-migraine spirocycles

BRISTOL MYERS SQUIBB CO13 citations83
US7772244B2Aug 10, 2010

Therapeutic agents for the treatment of migraine

BRISTOL MYERS SQUIBB CO12 citations83
US7314883B2Jan 1, 2008

Anti-migraine treatments

BRISTOL MYERS SQUIBB CO12 citations83
US10266578B2Apr 23, 2019

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

BRISTOL MYERS SQUIBB CO9 citations82
US7220862B2May 22, 2007

Calcitonin gene related peptide receptor antagonists

BRISTOL MYERS SQUIBB CO11 citations81
US7244746B2Jul 17, 2007

Imidazolyl derivatives as corticotropin releasing factor inhibitors

BRISTOL MYERS SQUIBB CO9 citations74
US10968219B2Apr 6, 2021

3-substituted propionic acids as αV integrin inhibitors

BRISTOL MYERS SQUIBB CO2 citations68
US7125990B2Oct 24, 2006

Imidazolyl derivatives as corticotropin releasing factor inhibitors

BRISTOL MYERS SQUIBB CO3 citations63
US12097242B2Sep 24, 2024

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

BRISTOL MYERS SQUIBB CO0 citations61
US12097241B2Sep 24, 2024

Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides

BRISTOL MYERS SQUIBB CO0 citations61
US11364281B2Jun 21, 2022

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof

BRISTOL MYERS SQUIBB CO0 citations61
US11185570B2Nov 30, 2021

Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides

BRISTOL MYERS SQUIBB CO0 citations61
US7449586B2Nov 11, 2008

Processes for the preparation of CGRP-receptor antagonists and intermediates thereof

BRISTOL MYERS SQUIBB CO4 citations61
US11884661B2Jan 30, 2024

3-substituted propionic acids as αV integrin inhibitors

BRISTOL MYERS SQUIBB CO0 citations58
US7470680B2Dec 30, 2008

Constrained compounds as CGRP-receptor antagonists

BRISTOL MYERS SQUIBB CO1 citations51

IMMUNOME INC

6 patents

ZENO MAN INC

1 patent